Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 904834, 13 pages
http://dx.doi.org/10.1155/2014/904834
Research Article

Salidroside Stimulates Mitochondrial Biogenesis and Protects against H2O2-Induced Endothelial Dysfunction

1Department of Pharmacology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
2The Key Laboratory of Drug Target Research and Pharmacodynamic Evaluation of Hubei Province, Wuhan 430030, China

Received 13 February 2014; Accepted 19 March 2014; Published 24 April 2014

Academic Editor: Shiwei Deng

Copyright © 2014 Shasha Xing et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. V. Makarenko, P. V. Usatyuk, G. Yuan et al., “Intermittent hypoxia-induced Endothelial barrier Dysfunction requires ROS-dependent MAP kinase activation,” American Journal of Physiology Cell Physiology, 2014. View at Publisher · View at Google Scholar
  2. N. Hermida and J. L. Balligand, “Low-density lipoprotein-cholesterol-induced endothelial dysfunction and oxidative stress: the role of statins,” Antioxidants & Redox Signaling, vol. 20, no. 8, pp. 1216–1237, 2013. View at Publisher · View at Google Scholar
  3. S. Wang, M. Zhang, B. Liang et al., “AMPKα2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes,” Circulation Research, vol. 106, no. 6, pp. 1117–1128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. C. M. Sena, A. M. Pereira, and R. Seica, “Endothelial dysfunction—a major mediator of diabetic vascular disease,” Biochimica et Biophysica Acta, vol. 1832, no. 12, pp. 2216–2231, 2013. View at Google Scholar
  5. A. L. Moens, R. Kietadisorn, J. Y. Lin, and D. Kass, “Targeting endothelial and myocardial dysfunction with tetrahydrobiopterin,” Journal of Molecular and Cellular Cardiology, vol. 51, no. 4, pp. 559–563, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Dromparis and E. D. Michelakis, “Mitochondria in vascular health and disease,” Annual Review of Physiology, vol. 75, pp. 95–126, 2013. View at Google Scholar
  7. E. Marzetti, A. Csiszar, D. Dutta, G. Balagopal, R. Calvani, and C. Leeuwenburgh, “Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 305, no. 4, pp. H459–H476, 2013. View at Google Scholar
  8. J. R. Mercer, “Mitochondrial bioenergetics and therapeutic intervention in cardiovascular disease,” Pharmacology & Therapeutics, vol. 141, no. 1, pp. 13–20, 2014. View at Google Scholar
  9. R. O. Poyton, K. A. Ball, and P. R. Castello, “Mitochondrial generation of free radicals and hypoxic signaling,” Trends in Endocrinology and Metabolism, vol. 20, no. 7, pp. 332–340, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. S. R. Thomas, P. K. Witting, and G. R. Drummond, “Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities,” Antioxidants & Redox Signaling, vol. 10, no. 10, pp. 1713–1765, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. M. T. Sorbara and S. E. Girardin, “Mitochondrial ROS fuel the inflammasome,” Cell Research, vol. 21, no. 4, pp. 558–560, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Banfi, M. Brioschi, S. S. Barbieri et al., “Mitochondrial reactive oxygen species: a common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial cells,” Journal of Thrombosis and Haemostasis, vol. 7, no. 1, pp. 206–216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. Ungvari, Z. Orosz, N. Labinskyy et al., “Increased mitochondrial H2O2 production promotes endothelial NF-κB activation in aged rat arteries,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 293, no. 1, pp. H37–H47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Addabbo, B. Ratliff, H.-C. Park et al., “The krebs cycle and mitochondrial mass are early victims of endothelial dysfunction: proteomic approach,” American Journal of Pathology, vol. 174, no. 1, pp. 34–43, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. M. Davidson and M. R. Duchen, “Endothelial mitochondria: contributing to vascular function and disease,” Circulation Research, vol. 100, no. 8, pp. 1128–1141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. A. Kluge, J. L. Fetterman, and J. A. Vita, “Mitochondria and endothelial function,” Circulation Research, vol. 112, no. 8, pp. 1171–1188, 2013. View at Google Scholar
  17. K. J. Krishnan, A. K. Reeve, D. C. Samuels et al., “What causes mitochondrial DNA deletions in human cells?” Nature Genetics, vol. 40, no. 3, pp. 275–279, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. M. G. Rosca and C. L. Hoppel, “Mitochondria in heart failure,” Cardiovascular Research, vol. 88, no. 1, pp. 40–50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. A. P. Halestrap, “Calcium, mitochondria and reperfusion injury: a pore way to die,” Biochemical Society Transactions, vol. 34, part 2, pp. 232–237, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Gutierrez, S. W. Ballinger, V. M. Darley-Usmar, and A. Landar, “Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells,” Circulation Research, vol. 99, no. 9, pp. 924–932, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Ungvari, N. Labinskyy, S. Gupte, P. N. Chander, J. G. Edwards, and A. Csiszar, “Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 294, no. 5, pp. H2121–H2128, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Blake and I. A. Trounce, “Mitochondrial dysfunction and complications associated with diabetes,” Biochimica et Biophysica Acta, vol. 1840, no. 4, pp. 1404–1412, 2014. View at Publisher · View at Google Scholar
  23. R. C. Scarpulla, “Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network,” Biochimica et Biophysica Acta, vol. 1813, no. 7, pp. 1269–1278, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. I. S. Patten and Z. Arany, “PGC-1 coactivators in the cardiovascular system,” Trends in Endocrinology and Metabolism, vol. 23, no. 2, pp. 90–97, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. R. C. Scarpulla, “Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator,” Annals of the New York Academy of Sciences, vol. 1147, pp. 321–334, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Santos, S. Tewari, A. F. X. Goldberg, and R. A. Kowluru, “Mitochondrial biogenesis and the development of diabetic retinopathy,” Free Radical Biology and Medicine, vol. 51, no. 10, pp. 1849–1860, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. Q. Xu, P. Xia, X. Li, W. Wang, Z. Liu, and X. Gao, “Tetramethylpyrazine ameliorates high glucose-induced endothelial dysfunction by increasing mitochondrial biogenesis,” PLoS ONE, vol. 9, no. 2, Article ID e88243, 2014. View at Google Scholar
  28. A. Panossian and H. Wagner, “Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration,” Phytotherapy Research, vol. 19, no. 10, pp. 819–838, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. E. W. Qian, D. T. Ge, and S.-K. Kong, “Salidroside promotes erythropoiesis and protects erythroblasts against oxidative stress by up-regulating glutathione peroxidase and thioredoxin,” Journal of Ethnopharmacology, vol. 133, no. 2, pp. 308–314, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Li, J. Sipple, Q. Pang, and W. Du, “Salidroside stimulates DNA repair enzyme Parp-1 activity in mouse HSC maintenance,” Blood, vol. 119, no. 18, pp. 4162–4173, 2012. View at Google Scholar
  31. S. B. Leung, H. Zhang, C. W. Lau, Y. Huang, and Z. Lin, “Salidroside improves homocysteine-induced endothelial dysfunction by reducing oxidative stress,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 679635, 8 pages, 2013. View at Publisher · View at Google Scholar
  32. J. R. Williams, “The declaration of Helsinki and public health,” Bulletin of the World Health Organization, vol. 86, pp. 650–652, 2008. View at Publisher · View at Google Scholar
  33. E. A. Jaffe, R. L. Nachman, C. G. Becker, and C. R. Minick, “Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria,” The Journal of Clinical Investigation, vol. 52, no. 11, pp. 2745–2756, 1973. View at Google Scholar · View at Scopus
  34. Y. Bai, A. K. Suzuki, and M. Sagai, “The cytotoxic effects of diesel exhaust particles on human pulmonary artery endothelial cells in vitro: role of active oxygen species,” Free Radical Biology and Medicine, vol. 30, no. 5, pp. 555–562, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Song, F. Zhou, W. R. Chen, and D. Xing, “PDT-induced HSP70 externalization up-regulates NO production via TLR2 signal pathway in macrophages,” FEBS Letters, vol. 587, no. 2, pp. 128–135, 2013. View at Google Scholar
  36. K. Dasuri, P. Ebenezer, S. O. Fernandez-Kim et al., “Role of physiological levels of 4-hydroxynonenal on adipocyte biology: implications for obesity and metabolic syndrome,” Free Radical Research, vol. 47, no. 1, pp. 8–19, 2013. View at Google Scholar
  37. S. Jin, D. Lu, S. Ye et al., “A simplified probe preparation for ELISA-based NF-κB activity assay,” Journal of Biochemical and Biophysical Methods, vol. 65, no. 1, pp. 20–29, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Zhang, X. Yang, F. Bian et al., “TNF-α promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: crosstalk between NF-κB and PPAR-γ,” Journal of Molecular and Cellular Cardiology, vol. 72, pp. 85–94, 2014. View at Google Scholar
  39. L. Wang, H. Zhen, W. Yao et al., “Lipid raft-dependent activation of dual oxidase 1/H2O2/NF-κB pathway in bronchial epithelial cells,” American Journal of Physiology—Cell Physiology, vol. 301, no. 1, pp. C171–C180, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Zhou, A. S. Yazdi, P. Menu, and J. Tschopp, “A role for mitochondria in NLRP3 inflammasome activation,” Nature, vol. 469, no. 7329, pp. 221–226, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. V. Parra, V. Eisner, M. Chiong et al., “Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis,” Cardiovascular Research, vol. 77, no. 2, pp. 387–397, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Reers, T. W. Smith, and L. B. Chen, “J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential,” Biochemistry, vol. 30, no. 18, pp. 4480–4486, 1991. View at Google Scholar · View at Scopus
  43. T. Collins, “Biology of disease: endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion,” Laboratory Investigation, vol. 68, no. 5, pp. 499–508, 1993. View at Google Scholar · View at Scopus
  44. E. Schulz, T. Gori, and T. Münzel, “Oxidative stress and endothelial dysfunction in hypertension,” Hypertension Research, vol. 34, no. 6, pp. 665–673, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. F. Giacco and M. Brownlee, “Oxidative stress and diabetic complications,” Circulation Research, vol. 107, no. 9, pp. 1058–1070, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Briasoulis, D. Tousoulis, E. S. Androulakis, N. Papageorgiou, G. Latsios, and C. Stefanadis, “Endothelial dysfunction and atherosclerosis: focus on novel therapeutic approaches,” Recent Patents on Cardiovascular Drug Discovery, vol. 7, no. 1, pp. 21–32, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. M. C. Xu, H. M. Shi, H. Wang, and X. F. Gao, “Salidroside protects against hydrogen peroxide-induced injury in HUVECs via the regulation of REDD1 and mTOR activation,” Molecular Medicine Reports, vol. 8, no. 1, pp. 147–153, 2013. View at Google Scholar
  48. L. M. Yung, F. P. Leung, X. Yao, Z.-Y. Chen, and Y. Huang, “Reactive oxygen species in vascular wall,” Cardiovascular and Hematological Disorders—Drug Targets, vol. 6, no. 1, pp. 1–19, 2006. View at Google Scholar · View at Scopus
  49. M. Félétou and P. M. Vanhoutte, “Endothelial dysfunction: a multifaceted disorder,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 291, no. 3, pp. H985–H1002, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Fujimoto, T. Asano, M. Sakai et al., “Mechanisms of hydrogen peroxide-induced relaxation in rabbit mesenteric small artery,” European Journal of Pharmacology, vol. 412, no. 3, pp. 291–300, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. Z.-W. Yang, A. Zhang, B. T. Altura, and B. M. Altura, “Hydrogen peroxide-induced endothelium-dependent relaxation of rat aorta: involvement of Ca2+ and other cellular metabolites,” General Pharmacology, vol. 33, no. 4, pp. 325–336, 1999. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Ellis, M. Pannirselvam, T. J. Anderson, and C. R. Triggle, “Catalase has negligible inhibitory effects on endothelium-dependent relaxations in mouse isolated aorta and small mesenteric artery,” British Journal of Pharmacology, vol. 140, no. 7, pp. 1193–1200, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Zembowicz, R. J. Hatchett, A. M. Jakubowski, and R. J. Gryglewski, “Involvement of nitric oxide in the endothelium-dependent relaxation induced by hydrogen peroxide in the rabbit aorta,” British Journal of Pharmacology, vol. 110, no. 1, pp. 151–158, 1993. View at Google Scholar · View at Scopus
  54. H. Cai, Z. Li, S. Dikalov et al., “NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II,” The Journal of Biological Chemistry, vol. 277, no. 50, pp. 48311–48317, 2002. View at Publisher · View at Google Scholar · View at Scopus
  55. C. M. Wong, L. M. Yung, F. P. Leung et al., “Raloxifene protects endothelial cell function against oxidative stress,” British Journal of Pharmacology, vol. 155, no. 3, pp. 326–334, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. S. Dimmeler and A. M. Zeiher, “Nitric oxide—an endothelial cell survival factor,” Cell Death and Differentiation, vol. 6, no. 10, pp. 964–968, 1999. View at Google Scholar · View at Scopus
  57. W. T. Wong, S. L. Wong, X. Y. Tian, and Y. Huang, “Endothelial dysfunction: the common consequence in diabetes and hypertension,” Journal of Cardiovascular Pharmacology, vol. 55, no. 4, pp. 300–307, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. X.-F. Niu, C. W. Smith, and P. Kubes, “Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils,” Circulation Research, vol. 74, no. 6, pp. 1133–1140, 1994. View at Google Scholar · View at Scopus
  59. H. Cai, Z. Li, M. E. Davis, W. Kanner, D. G. Harrison, and S. C. Dudley Jr., “Akt-dependent phosphorylation of serine 1179 and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase 1/2 cooperatively mediate activation of the endothelial nitric-oxide synthase by hydrogen peroxide,” Molecular Pharmacology, vol. 63, no. 2, pp. 325–331, 2003. View at Publisher · View at Google Scholar · View at Scopus
  60. Z. Xia, M. Liu, Y. Wu et al., “N-acetylcysteine attenuates TNF-α-induced human vascular endothelial cell apoptosis and restores eNOS expression,” European Journal of Pharmacology, vol. 550, no. 1–3, pp. 134–142, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. S. Mohan, M. Hamuro, G. P. Sorescu et al., “IκBα-dependent regulation of low-shear flow-induced NF-κB activity: role of nitric oxide,” American Journal of Physiology—Cell Physiology, vol. 284, no. 4, pp. C1039–C1047, 2003. View at Google Scholar · View at Scopus
  62. J. R. Matthews, C. H. Botting, M. Panico, H. R. Morris, and R. T. Hay, “Inhibition of NF-κB DNA binding by nitric oxide,” Nucleic Acids Research, vol. 24, no. 12, pp. 2236–2242, 1996. View at Publisher · View at Google Scholar · View at Scopus
  63. E. Pineda-Molina, P. Klatt, J. Vázquez et al., “Glutathionylation of the p50 subunit of NF-κB: a mechanism for redox-induced inhibition of DNA binding,” Biochemistry, vol. 40, no. 47, pp. 14134–14142, 2001. View at Publisher · View at Google Scholar · View at Scopus
  64. L. Jornot, H. Petersen, and A. F. Junod, “Modulation of the DNA binding activity of transcription factors CREP, NFκB and HSF by H2O2 and TNFα. Differences between in vivo and in vitro effects,” FEBS Letters, vol. 416, no. 3, pp. 381–386, 1997. View at Publisher · View at Google Scholar · View at Scopus
  65. V. Oliveira-Marques, H. S. Marinho, L. Cyrne, and F. Antunes, “Role of hydrogen peroxide in NF-κB activation: from inducer to modulator,” Antioxidants & Redox Signaling, vol. 11, no. 9, pp. 2223–2243, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Hasegawa, T. Saito, T. Ogihara et al., “Blockade of the nuclear factor-κB pathway in the endothelium prevents insulin resistance and prolongs life spans,” Circulation, vol. 125, no. 9, pp. 1122–1133, 2012. View at Publisher · View at Google Scholar · View at Scopus
  67. E. Nisoli and M. O. Carruba, “Nitric oxide and mitochondrial biogenesis,” Journal of Cell Science, vol. 119, part 14, pp. 2855–2862, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. E. Nisoli, E. Clementi, C. Paolucci et al., “Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide,” Science, vol. 299, no. 5608, pp. 896–899, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. D. Álvarez-Guardia, X. Palomer, T. Coll et al., “The p65 subunit of NF-B binds to PGC-1, linking inflammation and metabolic disturbances in cardiac cells,” Cardiovascular Research, vol. 87, no. 3, pp. 449–458, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. H.-J. Kim, K.-G. Park, E.-K. Yoo et al., “Effects of PGC-1α on TNF-α-induced MCP-1 and VCAM-1 expression and NF-κB activation in human aortic smooth muscle and endothelial cells,” Antioxidants & Redox Signaling, vol. 9, no. 3, pp. 301–307, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. A. Csiszar, N. Labinskyy, J. T. Pinto et al., “Resveratrol induces mitochondrial biogenesis in endothelial cells,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 297, no. 1, pp. H13–H20, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. J. Schilling, L. Lai, N. Sambandam, C. E. Dey, T. C. Leone, and D. P. Kelly, “Toll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxisome proliferator-activated receptor γ coactivator-1 signaling,” Circulation: Heart Failure, vol. 4, no. 4, pp. 474–482, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. J. C. Won, J.-Y. Park, Y. M. Kim et al., “Peroxisome proliferator-activated receptor-γ coactivator 1-α overexpression prevents endothelial apoptosis by increasing ATP/ADP translocase activity,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 2, pp. 290–297, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. I. Valle, A. Álvarez-Barrientos, E. Arza, S. Lamas, and M. Monsalve, “PGC-1α regulates the mitochondrial antioxidant defense system in vascular endothelial cells,” Cardiovascular Research, vol. 66, no. 3, pp. 562–573, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. F. Ali, N. S. Ali, A. Bauer et al., “PPARσ and PGC1α act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress,” Cardiovascular Research, vol. 85, no. 4, pp. 701–710, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. H. Cai, “Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences,” Cardiovascular Research, vol. 68, no. 1, pp. 26–36, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. Y.-M. Liu, B. Jiang, Y.-M. Bao, and L.-J. An, “Protocatechuic acid inhibits apoptosis by mitochondrial dysfunction in rotenone-induced PC12 cells,” Toxicology in Vitro, vol. 22, no. 2, pp. 430–437, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. H. Huang and K. G. Manton, “The role of oxidative damage in mitochondria during aging: a review,” Frontiers in Bioscience, vol. 9, pp. 1100–1117, 2004. View at Google Scholar · View at Scopus
  79. F. M. Yakes and B. van Houten, “Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 2, pp. 514–519, 1997. View at Publisher · View at Google Scholar · View at Scopus
  80. B. G. Hill, G. A. Benavides, J. R. Lancaster Jr. et al., “Integration of cellular bioenergetics with mitochondrial quality control and autophagy,” Biological Chemistry, vol. 393, no. 12, pp. 1485–1512, 2012. View at Google Scholar